Semaglutide 43835-0030-03
- Manufacturer
- Novo Nordisk Production Belgium Sa
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- June 5, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Semaglutide | 2 mg/mL |
Selected Package
43835-0030-03Selected1440 CONTAINER in 1 BOX (43835-0030-3) / 1 SYRINGE, GLASS in 1 CONTAINER / .5 mL in 1 SYRINGE, GLASS